Constant Guidance Financial »

Tg Therapeutics shares owned by Constant Guidance Financial

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Constant Guidance Financial from 13F filings

Historical chart of Constant Guidance Financial investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Constant Guidance Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Constant Guidance Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $230k 4.2k 54.94

More positions owned by Constant Guidance Financial

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust St Str Blo 1 Etf (BIL)
Apple (AAPL)
Ishares Tr Msci Emg Mkt Etf (EEM)
State Str Spdr Dow Jones Ind Ut Ser 1 (DIA)
Amazon (AMZN)
Bank of America Corporation (BAC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Duke Energy Corp Com New (DUK)
Alphabet Cap Stk Cl A (GOOGL)
Walt Disney Company (DIS)
NVIDIA Corporation (NVDA)

View all positions for Constant Guidance Financial

Top funds holding Tg Therapeutics

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
D. E. Shaw & Co
Soleus Capital Management
ClearBridge Advisors
Congress Asset Management
Two Sigma Investments
Jane Street
Goldman Sachs Group
Susquehanna International
Pictet Asset Management Holding SA
Nuveen

View all funds holding Tg Therapeutics